% | $
Quotes you view appear here for quick access.

Santarus, AŞ Message Board

  • neurodragon007 neurodragon007 Jun 21, 2013 8:50 AM Flag

    SNTS presenting Cycloset in Chicago...

    Cycloset will be featured in two poster presentations at the 73rd Scientific Sessions of the American Diabetes Association being held at McCormick Place in Chicago, Ill. from June 21 - 25, 2013.

    Poster #1. The Anti-Diabetes Efficacy of Bromocriptine-QR in Type 2 Diabetes Mellitus Subjects is Enhanced Among Those with Elevated Blood Pressure and Plasma Triglyceride Levels

    Poster #2 Bromocriptine-QR Attenuates the Progression to Both Cardiovascular Averse Events and Worsening Hyperglycemia in Type 2 Diabetes Mellitus Subjects in Good Glycemic Control

    Solid cardiac safety.. Cycloset is currently recommended as part of medical regimen in multi-cardiac risk patients. Patent until 2032. Nice upside here.

    Sentiment: Strong Buy